ExamFinch.com My Study

Study guide

Tricuspid & Pulmonic Valve Disease and Pulmonary Hypertension Assessment

Practice this exam

RDCS Adult Echocardiography AE

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

The RDCS AE Exam, SPI Requirement & Logistics Content Outline, Domain Weights & How to Study

2 Cardiac Anatomy

Chambers, Walls, Myocardial Layers & the 17-Segment Model Cardiac Valves & Subvalvular Apparatus Great Vessels, Pericardium, Coronary & Venous Anatomy

3 Cardiac Physiology & Hemodynamics

Cardiac Cycle, Phases & Pressure-Volume Relationships Normal Systolic & Diastolic Function Hemodynamic Principles & Response to Stress

4 Echo Modalities, Instrumentation & Contrast

2D (B-Mode) and M-Mode Imaging Spectral, Color, and Tissue Doppler Modalities Image Optimization, Artifacts, and Contrast Echocardiography

5 Standard Views, Windows & Protocol

Parasternal Long- & Short-Axis Views Apical Views Subcostal & Suprasternal-Notch Views Exam Protocol, Patient Positioning & Provocative Maneuvers

6 Quantification & Doppler Hemodynamic Calculations

Chamber Quantification: LV, LA, RA, and RV Size, Mass, and Volumes Systolic Function: Ejection Fraction Methods, Fractional Shortening & Strain Diastolic Function Grading (ASE/EACVI 2016) Core Doppler Math: Modified Bernoulli, VTI, Stroke Volume & the Continuity Equation Advanced Hemodynamics: PISA/EROA, Pressure Half-Time, dP/dt, Qp/Qs & RVSP

7 Aortic & Mitral Valve Disease

Aortic Stenosis Aortic Regurgitation Mitral Stenosis Mitral Regurgitation

8 Right-Sided, Prosthetic & Infective Valve Disease

Tricuspid & Pulmonic Valve Disease and Pulmonary Hypertension Assessment Infective Endocarditis and Vegetations Prosthetic Valves and Postoperative Evaluation

9 Ischemic Disease & Cardiomyopathies

Coronary Anatomy, Ischemic Heart Disease & Wall-Motion Abnormalities Stress Echocardiography & Myocardial Viability Mechanical Complications of Myocardial Infarction Dilated & Restrictive Cardiomyopathy Hypertrophic Cardiomyopathy, SAM & LVOT Obstruction

10 Pericardial Disease, Masses & Aorta

Pericardial Effusion & Cardiac Tamponade Constrictive Pericarditis vs. Restrictive Physiology Cardiac Masses, Tumors & Thrombi Aortic Disease: Aneurysm, Dissection & Atheroma

11 Congenital Heart Disease & Shunts

Septal Defects & Shunt Quantification Common Adult Congenital Lesions

12 Clinical Care & Safety

Patient Care, Clinical-Data Integration & Exam Protocols Bioeffects, ALARA, Infection Control & Ergonomics

Tricuspid & Pulmonic Valve Disease and Pulmonary Hypertension Assessment

Key Takeaways Explain This Topic AI

RVSP is estimated as RVSP = 4 x (TR Vmax)^2 + RAP, applying the modified Bernoulli equation to the peak tricuspid regurgitant jet velocity.

RAP is estimated from IVC diameter and inspiratory collapse: 3 mmHg (IVC <=2.1 cm, collapse >50%), 8 mmHg (indeterminate pattern), or 15 mmHg (IVC >2.1 cm, collapse <=50%).

TAPSE <17 mm indicates reduced right ventricular systolic function under ASE chamber-quantification criteria.

A TR Vmax >3.4 m/s indicates a high probability of pulmonary hypertension by echocardiographic screening criteria, while <=2.8 m/s (with no supportive signs) indicates low probability.

Carcinoid heart disease thickens, retracts, and fixes right-sided (tricuspid and pulmonic) leaflets because the lungs normally inactivate circulating serotonin, sparing the left heart.

Last updated: July 2026

Tricuspid Valve Disease

Trace-to-mild tricuspid regurgitation (TR) is a normal finding in most structurally normal hearts and requires no further workup. Pathologic TR, however, is overwhelmingly functional/secondary — annular dilation driven by RV pressure or volume overload (pulmonary hypertension, left heart disease, atrial fibrillation) rather than primary leaflet disease. Primary causes include rheumatic disease (leaflet thickening, doming, commissural fusion — less common on the TV than the MV), infective endocarditis, myxomatous prolapse, Ebstein anomaly, blunt trauma, and pacemaker/ICD lead-related TR from leaflet impingement, adhesion, or perforation. Carcinoid heart disease produces a distinctive pattern: thickened, retracted, immobile tricuspid (and pulmonic) leaflets that fail to coapt or open properly, because the lungs normally inactivate circulating serotonin and other vasoactive substances, sparing the left heart from the same process.

TR severity is graded using an integrated approach, not a single number:

  • Parameter Mild Severe
  • Vena contracta width <0.3 cm >=0.7 cm
  • Jet area (color) Small, central Large, often eccentric/wall-hugging
  • Hepatic vein flow Systolic dominant Systolic flow reversal
  • CW Doppler jet density Faint, parabolic Dense, triangular, early-peaking
  • Annulus diameter Normal Dilated (>4.0 cm or >21 mm/m^2)

Hepatic vein systolic flow reversal is one of the most specific signs of severe TR and should be actively sought whenever significant TR is suspected.

Tricuspid stenosis (TS) is rare and almost always rheumatic, typically accompanying mitral stenosis rather than occurring in isolation. A mean transtricuspid gradient greater than 5 mmHg (measured at a normal heart rate) is generally accepted as hemodynamically significant, though pressure half-time methodology is far less validated for TS than for MS.

Pulmonic Valve Disease

Like TR, trivial-to-mild pulmonic regurgitation (PR) is a common incidental finding in normal hearts. Pathologic PR most often follows repaired tetralogy of Fallot (the classic cause of severe, free PR requiring long-term surveillance), pulmonary hypertension with annular dilation, endocarditis, or carcinoid involvement of the right heart.

Pulmonic stenosis (PS) is overwhelmingly congenital and is the most common congenital lesion of the semilunar valves. Severity is graded by peak instantaneous gradient/velocity, analogous to but numerically distinct from aortic stenosis grading:

  • PS Severity Peak Velocity Peak Gradient
  • Mild <3 m/s <36 mmHg
  • Moderate 3-4 m/s 36-64 mmHg
  • Severe >4 m/s >64 mmHg
  • Pulmonary Hypertension Assessment

Echocardiography screens for pulmonary hypertension (PH) primarily through the tricuspid regurgitant jet. Right ventricular systolic pressure (RVSP), which equals pulmonary artery systolic pressure (PASP) in the absence of pulmonic stenosis, is calculated with the modified Bernoulli equation:

RVSP = 4 x (TR Vmax)^2 + RAP

Right atrial pressure (RAP) is not measured directly — it is estimated from inferior vena cava (IVC) diameter and its inspiratory collapse:

  • IVC Diameter Collapse with Sniff Estimated RAP
  • <=2.1 cm >50% 3 mmHg (range 0-5)
  • Indeterminate combination Indeterminate 8 mmHg (range 5-10)
  • >2.1 cm <=50% 15 mmHg (range 10-20)

Because TR Vmax alone drives most of the RVSP value, ASE echo-probability criteria grade the likelihood of PH directly from this velocity:

  • TR Vmax PH Probability
  • <=2.8 m/s (no other PH signs) Low
  • 2.9-3.4 m/s Intermediate
  • >3.4 m/s High

Supportive secondary signs (used to adjudicate the intermediate category and corroborate high-probability cases) include an RV/LV basal diameter ratio >1.0, a flattened or D-shaped interventricular septum, pulmonary artery acceleration time <105 ms (often with midsystolic notching), and an elevated early diastolic pulmonic regurgitant velocity. Right heart catheterization remains the diagnostic gold standard, with hemodynamic PH defined as a mean PA pressure >20 mmHg at rest — the echo estimate is a screening tool, not a substitute.

Right ventricular size and function must be assessed alongside pressure estimation, since RV failure — not the pressure number alone — drives symptoms and prognosis. Tricuspid annular plane systolic excursion (TAPSE), an M-mode measurement of longitudinal annular displacement, is the most widely used single quantitative index:

  • Parameter Abnormal (Reduced RV Function)
  • TAPSE <17 mm
  • RV fractional area change (FAC) <35%
  • Tissue Doppler S' <9.5-10 cm/s

TAPSE is easy to acquire and reproducible, but it is a load-dependent, single-segment (basal free wall) measurement and can be misleadingly normal in regional RV dysfunction or after cardiac surgery — always interpret it alongside RV size, FAC, and qualitative wall motion rather than in isolation.

Acquiring a Reliable RVSP

The TR jet used for RVSP must be optimized carefully: align the CW Doppler beam as parallel as possible to the jet, interrogating from multiple windows (parasternal RV inflow, apical four-chamber, subcostal) and taking the best, most complete envelope. Underestimating TR Vmax directly underestimates RVSP through the squared term in the Bernoulli equation, so a faint or truncated envelope should never be accepted at face value. When TR is trivial or absent, RVSP cannot be reliably estimated, and the study should instead rely on the secondary structural and Doppler signs above, reported qualitatively as low, intermediate, or high probability of pulmonary hypertension rather than as a specific pressure value.

RVSP is specific to the right ventricle and pulmonary artery in the absence of pulmonic stenosis; if pulmonic stenosis is present, RV systolic pressure and PA systolic pressure diverge and must be reported separately, since the RVSP calculation no longer directly represents pulmonary artery pressure.